Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000746500> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2000746500 endingPage "503" @default.
- W2000746500 startingPage "501" @default.
- W2000746500 abstract "It is postulated that the immune reaction on chemical carcinogens can inhibit or stimulate the chemical-induced carcinogenesis depending on the individual peculiarities of the synthesis of antibodies. Critical events take place on the barriers between external and internal media. Antibodies to chemical carcinogens, which are secreted into the digestive or bronchial tract, bind the environmental carcinogens and prevent them from penetrating into the blood through the epithelium and thereby inhibit the beginning of the tumour growth in any organs. On the contrary, the serum antibodies promote the penetration of carcinogens through the digestive and bronchial epithelia and thereby stimulate carcinogenesis in the proper organs. The other events take place in the organs such as breast and prostate where carcinogens are transported from the blood. Secretory antibodies bind carcinogens in the blood and transport them through the epithelium of these glands and thereby stimulate the tumour origin in these organs. Antibodies, which are not secreted into the ducts of breast and prostate, hold carcinogens in the blood and thereby inhibit carcinogenesis in these organs. Antibodies to steroid hormones function in the same way, i.e., secretory antibodies stimulate, while the serum antibodies inhibit the genetoxic action of the hormones on breast and prostate. The stimulation of carcinogenesis in the lymphoid cells is realized owing to hapten-specific binding of carcinogens by the membrane receptors of the corresponding clones. Antibodies to the natural inhibitors of carcinogenesis (retinoids, tocopherole, etc.) stimulate the beginning of the tumour growth. Antibodies to carcinogens and antiidiotypic antibodies to the cytochromes p-450 may act as abzymes, i.e., as cytochromes p-450 and thereby increase the level of the carcinogen metabolites." @default.
- W2000746500 created "2016-06-24" @default.
- W2000746500 creator A5003755736 @default.
- W2000746500 date "2002-11-01" @default.
- W2000746500 modified "2023-09-25" @default.
- W2000746500 title "Immunostimulation of the chemical-induced carcinogenesis in the phase of initiation MH-G 0166" @default.
- W2000746500 cites W1970926432 @default.
- W2000746500 cites W1982437398 @default.
- W2000746500 cites W1988973564 @default.
- W2000746500 cites W2121147434 @default.
- W2000746500 cites W2125174121 @default.
- W2000746500 cites W58863749 @default.
- W2000746500 cites W1626634640 @default.
- W2000746500 doi "https://doi.org/10.1016/s0306-9877(02)00224-4" @default.
- W2000746500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12376071" @default.
- W2000746500 hasPublicationYear "2002" @default.
- W2000746500 type Work @default.
- W2000746500 sameAs 2000746500 @default.
- W2000746500 citedByCount "7" @default.
- W2000746500 countsByYear W20007465002012 @default.
- W2000746500 countsByYear W20007465002014 @default.
- W2000746500 countsByYear W20007465002016 @default.
- W2000746500 countsByYear W20007465002019 @default.
- W2000746500 countsByYear W20007465002021 @default.
- W2000746500 crossrefType "journal-article" @default.
- W2000746500 hasAuthorship W2000746500A5003755736 @default.
- W2000746500 hasConcept C114246631 @default.
- W2000746500 hasConcept C121608353 @default.
- W2000746500 hasConcept C134018914 @default.
- W2000746500 hasConcept C159654299 @default.
- W2000746500 hasConcept C185592680 @default.
- W2000746500 hasConcept C203014093 @default.
- W2000746500 hasConcept C502942594 @default.
- W2000746500 hasConcept C54355233 @default.
- W2000746500 hasConcept C55493867 @default.
- W2000746500 hasConcept C555283112 @default.
- W2000746500 hasConcept C71315377 @default.
- W2000746500 hasConcept C86803240 @default.
- W2000746500 hasConcept C8891405 @default.
- W2000746500 hasConceptScore W2000746500C114246631 @default.
- W2000746500 hasConceptScore W2000746500C121608353 @default.
- W2000746500 hasConceptScore W2000746500C134018914 @default.
- W2000746500 hasConceptScore W2000746500C159654299 @default.
- W2000746500 hasConceptScore W2000746500C185592680 @default.
- W2000746500 hasConceptScore W2000746500C203014093 @default.
- W2000746500 hasConceptScore W2000746500C502942594 @default.
- W2000746500 hasConceptScore W2000746500C54355233 @default.
- W2000746500 hasConceptScore W2000746500C55493867 @default.
- W2000746500 hasConceptScore W2000746500C555283112 @default.
- W2000746500 hasConceptScore W2000746500C71315377 @default.
- W2000746500 hasConceptScore W2000746500C86803240 @default.
- W2000746500 hasConceptScore W2000746500C8891405 @default.
- W2000746500 hasIssue "5" @default.
- W2000746500 hasLocation W20007465001 @default.
- W2000746500 hasLocation W20007465002 @default.
- W2000746500 hasOpenAccess W2000746500 @default.
- W2000746500 hasPrimaryLocation W20007465001 @default.
- W2000746500 hasRelatedWork W161652093 @default.
- W2000746500 hasRelatedWork W1986200349 @default.
- W2000746500 hasRelatedWork W2056966621 @default.
- W2000746500 hasRelatedWork W2061752523 @default.
- W2000746500 hasRelatedWork W2099760364 @default.
- W2000746500 hasRelatedWork W212428169 @default.
- W2000746500 hasRelatedWork W2413390670 @default.
- W2000746500 hasRelatedWork W2416560908 @default.
- W2000746500 hasRelatedWork W2419474103 @default.
- W2000746500 hasRelatedWork W4240069585 @default.
- W2000746500 hasVolume "59" @default.
- W2000746500 isParatext "false" @default.
- W2000746500 isRetracted "false" @default.
- W2000746500 magId "2000746500" @default.
- W2000746500 workType "article" @default.